Tuesday, October 31, 2017
Autophagy Neurotherapeutics and Torrey Pines Institute Announce Licensing Agreement

Autophagy Neurotherapeutics (ANT) and the Torrey Pines Institute for Molecular Studies (TPIMS) announced that they have entered into a licensing agreement to commercialize ANT’s novel small molecule drugs developed at TPIMS for treating Amyotrophic Lateral Sclerosis and Alzheimer’s disease. ..

Read More
Tuesday, October 10, 2017
TPIMS: Battling the Opioid Epidemic

Torrey Pines Institute for Molecular Sciences is currently working on a series of projects that could provide substantial treatment to those who are affected by this crisis.  ..

Read More
Saturday, July 09, 2016
Torrey Pines Institute’s Dr. Lawrence Toll and Dr. Akihiko Ozawa Awarded $2.1 Million Grant

Torrey Pines Institute for Molecular Studies’ Dr. Lawrence Toll and Dr. Akihiko Ozawa have been awarded a $2.1 million grant from the National Institutes of Health’s National Institute on Drug Abuse (NIDA). This grant will fund research to study “NPQ/Spexin the Endogenous Ligand for the Galanin Receptor 3”. ..

Read More
Tuesday, October 20, 2015
Assuage Pharmaceuticals, a Torrey Pines Institute Spinoff, awarded $1million

Assuage Pharmaceuticals Inc., focused on developing novel treatments for addiction and pain management, was recently awarded a $1 million Phase II Small Business Innovative Research (SBIR) Award from the National Institute on Drug Abuse (NIDA) within the National Institutes of Health (NIH) to continue work in developing a novel treatment for smoking cessation.  ..

Read More
Friday, May 02, 2014
Torrey Pines Institute Awarded $3.1 Million for Inflammation and Autoimmune Disease in Bi-Coastal Collaboration

The National Institute of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID) have awarded Torrey Pines Institute for Molecular Studies (TPIMS) a $3,094,096 grant to identify and characterize novel small molecule RORγ antagonists for the treatment of inflammatory autoimmune diseases.  ..

Read More
Friday, April 18, 2014
Akron Biotech Awarded SBIR Grant for Development of Novel Method to Isolate Adipose Derived Stem Cells

Akron Biotech, an innovative biotech company focused on serving the growing demands of the cell therapy industry,was awarded a Phase 1 Small Business Innovative Research (SBIR) Award from the National Institutes of Health to develop enzyme-based formulations for the isolation of stem cells from various tissues. The project is in collaboration with Dr. Gregg Fields, Vice President of Scientific Affairs at Torrey Pines Institute for Molecular Studies. ..

Read More
Monday, January 28, 2013
Torrey Pines Institute inks research pact with Envoy Therapeutics

Torrey Pines Institute for Molecular Studies, a non-profit institute dedicated to conducting basic research to advance the understanding of human disease and the improvement of human health, has initiated a research collaboration with Envoy Therapeutics, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. ..

Read More
Friday, November 09, 2012
Libby Handel, Ph.D. Joins Torrey Pines Institute as Director of Business Development

Libby Handel, Ph.D. has been named Director of Business Development at Torrey Pines Institute for Molecular Studies where she will be responsible for commercializing research and technologies, creating and managing spin-off companies, and directing technology licensing activities. ..

Read More
Thursday, September 27, 2012
Torrey Pines awarded $2 million grant to fight alcohol liver disease

Heavy alcohol consumption is known to be the main cause of alcohol liver disease (ALD), but understanding the cellular interactions involved in livery injury following alcohol ingestion is poorly understood. By investigating “natural killer T-cells” and their functions in ALD, Dr. Vipin Kumar and his colleagues at Torrey Pines Institute for Molecular Studies are identifying new mechanisms to protect liver injury associated with ALD, thanks to a $2 million grant awarded by the National Institute of Health and National Institute on Alcohol Abuse and Alcoholism (NIAAA). ..

Read More
Sunday, September 23, 2012
Torrey Pines researcher awarded $2 million grant to fight breast cancer

Dr. Barbara M. Mueller and researchers at Torrey Pines Institute for Molecular Studies are identifying new mechanisms to treat late-stage breast cancer, thanks to a $2 million grant awarded by the National Institute of Health and the National Cancer Institute. ..

Read More